Non-Inferiority Trials – Bridge or Barrier to Patient-Centered Progress?

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Amgen; Bayer AG; Edwards Lifesciences; V-Wave; Medtronic; Recor Medical</li><li>Equity/Stock(s)/Options - Cordis Corporation, a Johnson & Johnson company</li></ul>